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Dextrans  are naturally occurring high  molecular weight  homopolysaccharides of 
D-glucose residues linked predominantly a(1 --~ 6)  (1). Class I dextrans are considered 
to have a  comblike structure with a  linear backbone of a(1 ~  6)-linked glucoses, and 
short branches of one or two glucoses linked a(1 ~  2), a(1 ~  3), or c~(1 ---) 4)  (1-3). 
Class II dextrans have sequences of alternating a(1 ~  3) and a(1 ~  6)  glucoses, and 
side chains of a(1 ~  6)-linked glucoses (4)  or a  more ramified structure with longer 
branches of alternating a(1 ~  3) and a(1 ~  6)-linked residues (5). 
Immunochemical  studies  of antibodies  from  human  and  rabbit  antisera,  mouse 
myeloma proteins, and mouse hybridoma antibodies to dextran B512, a class I dextran 
with 95% a(1 ~  6) linkages and 5% a(1 ~  3) linkages at branch points, have yielded 
valuable  insights  into  the  size,  shape,  and  specificity of antibody-combining sites, 
essentially because of the simple, well-defined structure of this dextran  (6-9). 
Dextran B1355S  is a  more complex class II dextran, with  54%  a(1 ~  6)  and 46% 
a(1 ~  3)  linkages, with  11%  of the a(1 --~ 3)  at branch  points (3), and uncertainties 
remain  as  to  its  precise  structure  and  therefore  as  to  the  nature  of  its  antigenic 
determinants.  Immunochemical characterization of the combining sites of myeloma 
proteins  binding  dextran  B1355S,  CAL20  TEPC1035  (IgG2b~¢), J558  (IgA~),  and 
MOPC104E  (IgM]k)  have  previously  been  reported  (10-12),  but  because  specific 
myeloma proteins are found  fortuitously by screening pristane-induced plasmacyto- 
mas (13), they do not provide insight into the repertoire of the response to B 1355S. A 
set of 10 mouse hybridoma antibodies to dextran B1355S has been studied, and amino 
acid sequences of their heavy chain V-regions (14)  as well as their private and cross- 
reactive idiotypes have been determined (15). This information is considered with the 
results presented here of an immunochemical study of the combining site specificities 
of some of these and additional hybridoma antibodies. 
* Supported by grant  PCM 81-02321 from the National Science Foundation  to E. A. Kabat: by Cancer 
Center Support  Grant  CA 13696 to Columbia University: grants AI 15926 and AI 15353 fronl the U. S. 
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Materials and Methods 
Immunization.  BALB/c  or  (BAB14  ×  BRVR)F1  mice were  immunized by  two  methods. 
Primary immunization consisted of an injection of  100/zg of B1355S  in complete Freund's 
adjuvant. Hyperimmunization involved primary immunization followed by three injections of 
2  ×  109 Escherichia coli at 2-d intervals l  mo later.  Fusions were performed 5-7 d  after  final 
immunization. 
Production of  Hybridomas.  The procedure used was essentially that ofGalfr~ et al. (16). Briefly, 
l0  s spleen cells from dextran-immunized mice were fused with at least 10  ~ HGPRT- MPC11 
(Hdex  1 and 3), NS1  (Hdex 2, 6, 9 and 31), or Sp2/O-Agl4 (Hdex  11,  12,  14, 24, 25, and 36) 
cells using polyethylene glycol (Carbowax 1500 [ 1,500 mol wt]; Fisher Scientific Co., Pittsburgh, 
PA). The cell lines were  generously supplied by Dr.  M.  Scharff (Albert Einstein College of 
Medicine, New York), Dr. C. Milstein (Medical Research Council, Cambridge, England), and 
Dr. G. Kghler (Basel Institute for Immunology, Basel, Switzerland) (17-19), respectively. After 
fusion, cells were grown in hypoxanthine, aminopterin, thymidine selection media (20)  in 24- 
well culture plates. Dextran-binding proteins were detected either by isoelectric focusing or by 
radioimmunoassay. Hybrids were cloned in soft agar over 3T3 feeder layers (21) and grown in 
BALB/c mice as ascites tumours. 
Dextrans.  Native dextrans have been described previously (1-5)  and were  obtained from 
Northern Regional Research Center, U. S. Dept. of Agriculture, Peoria, IL. Synthetic dextran 
V39  was  provided  by  Dr.  C.  Schuerch,  State  University of New  York,  Syracuse,  NY.  The 
molecule has a linear backbone of about 213 a(1 ---* 6)-linked D-glucopyranosyl units with ~27 
single glucose (GIc) I side chains linked (l ~  3) in a  ratio of 95% a/5% fl linkages. About 15%, 
by weight, consists of units 
---+601 ca 1---* 
Glc 
4% of units 
---~6Glcal ~  6GI cal---~ 
G1 c  GI c 
and <1% of units with three branch points in a  row.  Unbranched segments vary widely in 
length. 
Quantitative Precipitin  Assay.  The procedure has been previously outlined (22).  A  constant 
amount of antibody, 4-7.3 #g antibody nitrogen (AbN), was added to varying quantities, 0-60 
#g, of dextran; the total volume was 280 or 400/11.  After incubation for 1 h at 37°C, and 5-7 
d  at 4°C with daily mixing, AbN in the washed  precipitates was determined by Ninhydrin 
assay. The precipitin patterns and the classification into groups were not affected by the total 
volume or  amount  of AbN  chosen,  and  lower  amounts of AbN  permitted  use  of smaller 
quantities of scarce oligosaccharides in inhibition assays. 
Amino Acid Sequences.  VH amino acid sequences of MOPC104E, J558, and Hdex  1 through 
10 have been reported previously (14, 23, 24). The sequences of Hdex  11, 12, 14, 24, 25, 31, and 
36 will be published elsewhere.  2 Amino acid positions are denoted by sequential and homolo- 
gized numbering (24)  in square brackets [  ] to facilitate comparisons with other VH chains. 
1  Abbreviations used in this paper: CDR, complementarity determining region; FR, framework region; Glc, 
glucose IdI, individual idiotype; IdX, cross-reactive idiotype. Amino acid code: A, Ala; R, Arg; N, Ash; D, 
Asp; C, Cys; Q, Gin; E, Glu; G, Gly; H, His; I, Ile; L, Leu; K, Lys; M, Met; F, Phe; P, Pro; S, Ser; T, Thr; 
W, Trp; Y, Tyr; and V, Val. 
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Results 
Quantitative Precipitin Assays.  The results in Table I and Fig. 1 show the relationships 
among the  hybridoma  (Hdex)  antibodies  from quantitative  precipitin  assays with 
numerous dextrans. The maximum precipitation of any dextran  (- to ++++) and the 
amount  required  for 50%  of maximum precipitation  relative to  B1355S  are given. 
When the antibodies are arranged in order of increasing cross reactivity, five groups 
are seen. Previously characterized mouse myeloma proteins CAL20 TEPC 1035, J558, 
and MOPC104E  fit into groups 1, 3, and 5, respectively (10-12). 
From Fig.  1, it is apparent that all hybridoma antibodies react maximally and to 
similar extents with class II dextrans, B 1355S, B 1498S,  and B 1501 S; the classification 
into  groups therefore is based on the varying extents to which  cross reactions with 
class I dextrans occur. 
In group  1, CAL20 TEPC1035,  and Hdex  12,  25,  and 31,  react with none of the 
class I dextrans. However, beginning with group 2, once a class I dextran shows some 
cross-reactivity,  it  continues  to  precipitate  in  all  succeeding  groups.  Hdex  36  is 
precipitated  by B742S,  but  this curve enters the antigen  excess zone sooner than  is 
seen with  other antibodies  binding  this  dextran.  This  is  probably due  to  Hdex  36 
being IgG3X, whereas  all other  Hdex antibodies  are  IgM)~.  The three  members of 
group  3,  Hdex 6,  9,  and J558,  also react with  B742S.  In  addition,  proteins  in  this 
group cross-react somewhat with  three or four other  dextrans:  Hdex 6  and  9  with 
B1299S,  B1355L,  and  B1255,  and J558  (10,  11)  with  B1299S,  B1255,  B1375,  and 
B742L. 
Group 4, Hdex  1, 3, and 24 are precipitated to greater extents by B742S, B 1299S, 
and B1355L. With Hdex 3 and 24, B1255 reacts almost as well; B1375, B1254S, and 
B742L react less strongly. With Hdex 1, B 1255 behaves more like B742L and B 1254S, 
and B 1375 is only slightly active. 
Group  5  precipitates with  all  dextrans  reactive in  group  4,  and  is  distinguished 
from group 4 primarily by the greater precipitating power of dextrans B 742S, B 1299S, 
B1355L,  and B1255.  This is seen most strikingly with  Hdex  11  and  14;  B1255  and 
B1355L  appear somewhat less active with  Hdex  2.  Less strongly reacting dextrans 
include  B1375  and B1254S, which behave similarly, followed in decreasing order of 
activity by B742L, B 1141, and possibly B 1501L. 
The  remaining  class  I  dextrans  B1498L,  B1351S,  B512,  B1399,  B1425,  Bl142, 
B1424, and the synthetic dextran V39 do not react with any of the Hdex antibodies 
with which they were tested. 
Dextran Structure and Reactivity.  The structural compositions of these dextrans to the 
extent that they are currently known may be found in refs. 1-5. The three maximally 
reacting class II dextrans, B 1355S,  B 1498S,  and B 1501S,  are similar in linkages and 
degrees of branching:  54-67%  a(1  ~  6)  and  33-46%  c~(1 --~ 3),  with  9-11%  of the 
c~(l ~  3)  at  branch  points  (3);  all  are  proposed  to  have an  alternating  t~(1 ~  3), 
o~(l --~ 6) sequence (4, 5). 
Two strongly cross-reactive class I dextrans in groups 4 and 5, B1299S and B742S 
both have highly branched structures with 35% a(1 ~  2) and 50% a(1 ~  3) linkages 
at  branch  points,  respectively  (3).  However,  two  other  strongly  reactive  dextrans, 
B1355L  and B1255,  have infrequent  branching  (2,  3).  B1355L,  with ~5% a(1 --~ 3) 
branch  points  (3),  appears  similar  to  B512,  which  is  nonreactive  in  all  precipitin 
groups,  and  thus  its  reactivity is  puzzling.  It  is  known  that  B1355L  is  synthesized T
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Fro,  1.  Quantitative precipitin analysis of the ttdex antibodies. 
simultaneously  with  B1355S  in  the  same  culture  containing  an  enzyme  capable  of 
forming alternating  a(1 --*  3)  and c~(1 ~  6)  linkages  (25),  and perhaps  it  contains  a 
small percentage of these alternating  sequences. 
B1254S,  with  20%  a(1 --~  4)  (3),  and B1375,  with  26%  c~(1 --~  3)  (I)  branch  point 
linkages, respectively,  are both moderately cross reactive in groups 4  and 5. 
The very weakly reactive and nonreactive dextrans generally have low percentages 
of branched  residues  with  the  exception  of Bl142  (3);  its  failure  to  react  has  been 
observed previously  (26)  and is not understood. 
Little  is  known  about  the  distribution  of the  side  chains,  i.e.,  the  spacing  of the 
"teeth"  on the proposed  comblike class  I  dextrans,  which  would provide  the  multi- 
valent  determinants  for the cross reactions.  Some of the apparent  inconsistencies  in LId 
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the correlation of dextran composition with the precipitin assays may be resolved by 
further structural study of these dextrans. 
Vn  Amino  Acid  Sequences and  Idiotypes.  The  VH  regions  of all  dextran-binding 
proteins except CAL20 TEPC1035 and Hdex 36 have been sequenced (14, 23)  2 and 
their idiotypic determinants characterized (15). 2 The sequences of the heavy chains 
follow a  pattern of homology consistent with their origin from three gene segments, 
VH,  DH,  and JH. The proteins studied show four V  segments, V1, VI', Va, and V4 
(Table II), which correspond to amino acid positions 1-99 [1-95]. V1 is found in  10 
of 13 proteins. The other V  segments differing from V1 by 1, 4, and 2 amino acids, 
respectively, are each represented once. Eight different pairs of amino acids are found 
at positions 100, 101 [96, 97] which are encoded by DB gene segments; four J, regions 
are seen.  Table II  shows  that  individual  gene  segments  appear  to assemble  in  an 
unrestricted manner with other segments. 
The idiotypes of the  dextran-binding proteins have been  localized to  particular 
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TABLE II 
Association of Spec~'c~ty, Sequence, and Idiotype 
Specificity 
Sequence  ldiotypc 
\'H  I  99  I)H  100.  Idl 
[I  95[*  101  [96,  97]  JH  1(12  117  [98  1131  ldX  ldI  (,]558)  (MOPC101E) 
Group  1  Hde×  12  I"  GN  Y  R  -  A  Y  -  -  Q-  -  -  v  -  -  -  .]:~  ++  -  - 
Hdex  25  l  SY  ................  .],  ++  -  - 
Hdcx  31  1  RY  YAM  Y--Q--S  ....  J4  ++  ++  - 
Group  2  Hdcx  36  '  ?  i'  +4-  ++  - 
Group  3  Hdex  6  1  SH  ...............  J'~  ++  -  - 
Hdex  9  3  RY  --  ...............  Ji  ++  ++  -- 
J558  I  RY  ...............  Jj  ++  ++  - 
Gioup  4  Hdcx  I  l  NY  H  ....  V  -  .......  Jl'  ++  +  - 
Hdcx  24  I  SS  Y  -  -  -  Y  -  -  Q-  -  -  L  -  -  -  J~  q-+  -  - 
Hdex  3  I  RI)  ...............  .Ja  ++  -  - 
Group  5  MOPCI04E  1  YI)  WYF  1)\  WGAGTTVTVS  S  .1~  ++  -  ++ 
Hdex  14  4  YI)  ................  ,]~  ---  --  ++ 
Hdcx  1 I  I  YI)  I:  -  --  -  Y  -  -- Q-  -  -  L  -  -  -  -  Ja  ++  -  ++ 
Hdcx  2  1  NY  ................  JI  ++  +  -- 
* The  VH 1 sequence  of MOPCI04E  is reported  in ~ef~. 23, 24.  \"~ 1' of t'ldux  [2 differs with  N  al  position  63 [62]  instead  of K;  Vtt3 of Hdex  9  has  R, H, 
N, and  F  at positions  6~  [62 l,  73 [72],  771761, and  80179[.  t cspec¢ivc[.v,  instead  of K. 1). S, and  "t'~ V~4  ~ff Hdex  I4 t-tas K,  K  at  positions  54,  55 [53.54  I 
instead  of N,  N 
regions of the heavy chain. Cross-reactive idiotype (IdX) determinants are correlated 
with amino acid residues 54, 55 [53, 54] in the second hypervariable region (CDR2), 
and  only in  V4  (Hdex  14)  are  KK  substituted  for  NN.  Both  individual  idiotype 
(IdI)(MOPC104E)  and IdI(J558)  determinants are associated with DH residues  100, 
101  [96,  97]  in the third hypervariable region (CDR3);  IdI(J558)  is correlated with 
RY and IdI(MOPC104E) with YD at these positions (Table If). 
VH  and  JH  segments  do  not  appear  to  be  restricted  to  any  precipitin  group. 
Similarly,  IdX  determinants  are  found  on  molecules  in  all  groups.  However,  DH 
residues  and  IdI  determinants  may  correlate, although  imperfectly, with  binding 
specificities.  In  groups  1 and  3,  two  out  of five  Hdex  antibodies  and J558  carry 
IdI(J558)  determinants and have RY Dn segments; the other three antibodies, with 
GN, SY, and SH, lack IdI(J558). The only antibody in group 2, Hdex 36, expresses 
an IdI(J558)  determinant, although its DH residues are still unknown. Thus four of 
seven proteins in groups 1, 2, and 3 express IdI(J558). Two of seven proteins in groups 
4 and 5 partially express IdI(J558)  and both have NY at  100,  101  [96, 97].  A better 
correlation is found in group 5 in which two of three Hdex antibodies and MOPC 104E 
have IdI(MOPC 104E) determinants and YD Dn segments. Five proteins lacking both 
IdI(J558)  and  IdI(MOPC104E)  fall  into three groups;  each differs at  amino  acid 
positions  100,  101  [96,  97],  suggesting  that  they  might  represent  additional  IdI 
specificities. 
Discussion 
Quantitative precipitin studies, similar to those with blood group substances and 
monoclonal anti-I and anti-i sera (27), reveal significant differences in combining site 
specificities among 12 mouse hybridoma antibodies to dextran B 1355S. The spectrum 
appears greater than that seen in 12 mouse hybridomas to dextran B512 (9), reflecting 
the greater structural complexity of B 1355S.  However, immunization, fusion, screen- 
ing, subcloning, and culturing procedures for obtaining hybridomas may affect the 
findings by favoring certain clones, perhaps those growing faster or secreting immu- NEWMAN ET AL.  137 
noglobulins of higher affinity. Such  factors could be responsible for the  failure on 
immunization of mice with B1355S  to obtain hybridoma antibodies cross reacting 
with B512, which have been seen in humans immunized with this dextran (6, 28, 29). 
Thus, the five-group classification may not include the entire repertoire (30). 
The precipitation of all of the Hdex antibodies with class II dextrans suggests that 
the sequence of alternating a(1 ~  6)  and a(1 ~  3)-linked glucoses is the preferred 
determinant. In rabbits injected with B1355S, two distinct populations of antibodies 
specific for the alternating sequence were seen, with the a(1 ~  6)  or the a(1 ~  3) 
linkage being immunodominant  (31).  Quantitative precipitin inhibition studies (un- 
published)  show  that  tri-  and  tetrasaccharides  with  alternating  a(1  ~  3)  and 
a(1 ~  6)-linked glucoses are the best inhibitors thus far found of the precipitation of 
the Hdex antibodies with B1355S.  They are better than nigerosyl a(1  --~  3)-linked 
oligosaccharides  of the  same  size;  the  a(1  --9  6)-linked  isomaltosyl  series  does  not 
inhibit.  Larger  oligosaccharides,  as  well  as  alternating  oligosaccharides  with  side 
chains,  are  needed  for a  more complete definition of the combining sites.  CAL20 
TEPC1035 (group 1) is inhibited best by panose, Glcal ~  6Glca 1 ~  4Glc (10), which 
does  not  inhibit  any  of the  Hdex  antibodies  or  MOPC104E.  It  was  previously 
suggested  (10)  that  the combining site of CAL20 TEPC1035 might be most specific 
for an unknown molecule containing a  panose-like determinant with which class II 
dextrans  cross  react.  Therefore, the  CAL20  TEPC1035  combining  site  specificity 
differs from the group 1 Hdex antibody sites, although the precipitin patterns appear 
identical. 
Inclusion within a group therefore implies similarity but not necessarily identity of 
binding specificity. Indeed, with the exception of group 1, in which the precipitation 
pattern  of all  proteins  is  indistinguishable,  no  other proteins  show  such  identical 
binding  specificities.  Although  one  could  legitimately  consider  each  protein  as  a 
separate group, it may be more useful to cluster them into five groups of gradually 
increasing cross-reactivity patterns, if only to determine which structural features of 
the variable regions may be responsible for binding specificity. 
As  seen  in  Table  II,  the  group  1  precipitin  pattern  is  shared  by  three  Hdex 
antibodies with very different amino acid sequences in the third hypervariable region 
(CDR3)  and FR4. From the inhibition data, the combining sites are specific for the 
alternating a(1 --~ 3)  and a(1 --~ 6)  linkages, but precipitin analyses show that they 
cannot accommodate cross reacting determinants on class I dextrans; the other groups 
of Hdex antibodies also have sites specific for the alternating sequence with perhaps, 
a subsite that accommodates class I determinants. Conceivably, access to this subsite 
might  be blocked by side chains of one or more amino acid substitutions  through 
steric hindrance, conformational changes, or charge effects. For example, R  103 [99] 
in Hdex 12 (group  1), with a long positively charged side chain, replaces Y  103 [99], 
found in all of the cross reactive Hdex antibodies. It is of interest that in sites of the 
serine  proteases,  the  presence  in  elastase  of valine  and  threonine  instead  of two 
glycines in chymotrypsin obstructs and thereby prevents hydrolysis of chymotrypsin 
substrates having bulky side chains (32). 
There are several instances in which proteins in different groups differ by only a 
single amino  acid.  Thus  Hdex25  (group  1), J558  (group  3),  and  Hdex2  (group  5) 
have S,  R, and N, respectively, at position  100 [96];  Hdex25  (group  1)  and  Hdex6 
(group 3) differ at position I01 [97] with Y and H, respectively. Whereas these residues 138  HYBRIDOMA ANTIBODIES TO DEXTRAN B1355S 
are obviously of importance to specificity, it  is  difficult  to  imagine how the  group 
classification could depend exclusively on single amino acid substitutions in VH. The 
light  chains,  although  )k,  most  probably  contribute  to  blocking  part  of  the  site 
responsible for the various cross reactivities, but final conclusions must await sequenc- 
ing of these chains. 
All proteins with RY at positions  100,  101  [96,  97]  are in groups  1 and 3, and all 
those  with  YD  are  in  group  5.  These  residues  are  associated  with  IdI(J558)  and 
IdI(MOPC 104E)  determinants and binding specificity appears to correlate somewhat 
with  these  markers.  That  not  every  protein  within  a  group  shares  the  same  DH- 
encoded residues suggests that similar binding specificities can be generated in more 
than one way, rather than that these residues are unimportant. 
Some  variable region  structures,  however,  do seem  unimportant  to  the  binding 
specificity. For example, NN, at positions 54, 55 [53,  54] with an associated carbohy- 
drate side chain (14,  15) on N  55 [54],  is found on all proteins except Hdex 14 which 
has KK at these positions. The heavy chain of MOPC 104E differs from Hdex 14 only 
at these residues, and yet both proteins are in group 5. Jn regions also seem unrelated 
to binding patterns: J1 is found in four groups, J2 in two groups, and J3 and J4 occur 
only once each. 
These  findings  clearly establish  that  relatively minor changes  in  Vn  amino acid 
sequence  are  associated  with  major  differences  in  binding  specificity.  The  data 
presented here put in perspective the gaps in our understanding of the relationship of 
diversity to antibody site specificity and complementarity (33). 
Summary 
The combining sites of 12  mouse hybridoma antibodies  to dextran  B1355S  have 
been characterized by quantitative precipitin assay. All antibodies preferentially bind' 
the immunizing antigen B1355S and two other class II dextrans, B1498S and B1501S, 
but show substantial differences in the extents to which they cross react with class I 
dextrans, suggesting their clustering into five groups. Three myeloma proteins, CAL20 
TEPC1035,  J558,  and  MOPC104E,  which  bind  dextran  B1355S,  each  fall  into  a 
different group. There appears to be a  substantial, but imperfect, correlation of DH 
region structure and individual idiotypic determinants with dextran binding patterns. 
Proteins  with  RY DH segments and  IdI  (J558)  idiotypes are in groups  1 or 3,  and 
proteins  with  YD  DH segments  and  IdI  (MOPC104E)  idiotypes are  exclusively in 
group  5.  However, identical  patterns of precipitin  curves accompany very different 
sequences in CDR3.  Antibodies of group  1, which  react only with class II dextrans, 
differ the most in primary sequence, a  finding suggesting that suhsites responsible for 
cross reactivity with class I dextrans may be blocked and that this may be effected by 
side  chains  of different  amino  acids.  This  finding  delineates  a  new  aspect  of the 
relationship of variability in amino acid sequence to antibody complementarity. 
Received  for publication 2 August 198Z 
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